Objective: To study the characterization of Fe3O4@Au-C225 composite targeted MNPs.
Methods: Fe3O4@Au-C225 was prepared by the absorption method. The immunosorbent assay was used to evaluate its absorption efficiency at C225 Fc. ZETA SIZER3000 laser particle size analyzer, ultraviolet photometer and its characteristics were analyzed by VSM. the targeting effect of Fe3O4@Au-C225 composite targeted MNPs on U251 cells in vitro were detected by 7.0 Tesla Micro-MR; and subcutaneous transplanted human glioma in nude mice were performed the targeting effect in vivo after tail vein injection of Fe3O4@Au-C225 composite targeted MNPs by MRI.
Results: The self-prepared Fe3O4@Au composite MNPs can adsorb C225 with high efficiency of adsorption so that Fe3O4@Au-C225 composite targeted MNPs were prepared successfully. Fe3O4@Au-C225 composite targeted MNPs favorably targeted human glioma cell line U251 in vitro; Fe3O4@Au-C225 composite targeted MNPs have good targeting ability to xenografted glioma on nude mice in vivo, and can be traced by MRI.
Conclusion: The Fe3O4@Au-C225 composite targeted MNPs have the potential to be used as a tracer for glioma in vivo.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898739 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0195703 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
FeO@Au composite magnetic nanoparticles modified with cetuximab for targeted magneto-photothermal therapy of glioma cells.
Int J Nanomedicine
June 2018
Department of General Practice, Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Background: Thermoresponsive nanoparticles have become an attractive candidate for designing combined multimodal therapy strategies because of the onset of hyperthermia and their advantages in synergistic cancer treatment. In this paper, novel cetuximab (C225)-encapsulated core-shell FeO@Au magnetic nanoparticles (FeO@Au-C225 composite-targeted MNPs) were created and applied as a therapeutic nanocarrier to conduct targeted magneto-photothermal therapy against glioma cells.
Methods: The core-shell FeO@Au magnetic nanoparticles (MNPs) were prepared, and then C225 was further absorbed to synthesize FeO@Au-C225 composite-targeted MNPs.
Preparation and characterization of Fe3O4@Au-C225 composite targeted nanoparticles for MRI of human glioma.
PLoS One
July 2018
Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.
Objective: To study the characterization of Fe3O4@Au-C225 composite targeted MNPs.
Methods: Fe3O4@Au-C225 was prepared by the absorption method. The immunosorbent assay was used to evaluate its absorption efficiency at C225 Fc.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!